Progress toward developing a carbohydrate-conjugate vaccine against Clostridium difficile ribotype 027: synthesis of the cell-surface polysaccharide PS-I repeating unit

A Possible Oligosaccharide-Conjugate Vaccine Candidate for Clostridium difficile Is Antigenic and Immunogenic

(2011) Matthias A. Oberli et al.   CHEMISTRY & BIOLOGY

The emergence of ‘hypervirulence’ in Clostridium difficile

(2010) Stephen T. Cartman et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Economic healthcare costs of Clostridium difficile infection: a systematic review

(2010) S.S. Ghantoji et al.   JOURNAL OF HOSPITAL INFECTION

Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread

(2010) Archie CA Clements et al.   LANCET INFECTIOUS DISEASES

First Synthesis ofC. difficilePS-II Cell Wall Polysaccharide Repeating Unit

(2010) Elisa Danieli et al.   ORGANIC LETTERS

The potential value of Clostridium difficile vaccine: An economic computer simulation model

(2010) Bruce Y. Lee et al.   VACCINE

Synthesis of a Novel Polyhydroxylated Salicylic Acid Lactone Framework

(2009) J. S. Shane Rountree et al.   ORGANIC LETTERS

Clostridium difficile cell-surface polysaccharides composed of pentaglycosyl and hexaglycosyl phosphate repeating units

(2008) Jeyabarathy Ganeshapillai et al.   CARBOHYDRATE RESEARCH

Review of Current Literature on the Economic Burden of Clostridium difficile Infection

(2008) Erik R. Dubberke et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

New thioglycoside derivatives for use in odourless synthesis of MUXF3 N-glycan fragments related to food allergens

(2007) Mayeul Collot et al.   TETRAHEDRON